Never Ending: BioNTech’s CEO Says New Vaccines May Be Needed In 2022 To Protect From Emerging COVID Variants

• Future COVID-19 variants could evade current vaccines and boosters, the CEO of BioNTech told the FT.
• We may therefore need new COVID-19 vaccines my mid-2022, Ugur Sahin said.
• BioNTech and Pfizer codeveloped the US’ only fully approved COVID-19 vaccine

The world may need new COVID-19 vaccines by mid-2022 to protect against coronavirus mutations, BioNTech CEO Ugur Sahin told the Financial Times on Sunday.